 |
|
|
| |
Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: Week 48 results
|
| |
| |
IAC 2020 July 6-10
Moti Ramgopal, Midway Research
Reported by Jules Levin
|
| |
|
|
|
|
|
